Sarepta Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 785 | 0.0% | 36,471 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 703 | 0.0% | 36,471 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 2,216 | 0.0% | 129,562 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 8,269 | 0.0% | 129,562 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 16,215 | 0.0% | 133,362 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 17,030 | 0.0% | 136,362 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 25,037 | 0.0% | 158,462 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 20,796 | 0.0% | 160,639 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 16,546 | 0.0% | 171,581 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 21,065 | 0.0% | 173,772 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 18,877 | 0.0% | 164,840 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 11,954 | 0.0% | 86,733 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 11,818 | 0.0% | 91,200 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 9,971 | 0.0% | 90,200 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 6,965 | 0.0% | 92,915 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 7,476 | 0.0% | 95,700 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 8,843 | 0.0% | 98,200 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 8,166 | 0.0% | 88,300 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 6,631 | 0.0% | 85,300 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 6,581 | 0.0% | 88,300 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 17,623 | 0.0% | 103,368 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 15,637 | 0.0% | 111,352 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 20,751 | 0.0% | 129,417 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 12,847 | 0.0% | 131,332 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 16,769 | 0.0% | 129,952 | 12/31/2019 |